{"central venous catheterisation": 187.68, "condition aggravated": 5.11, "device related infection": 25.66, "drug ineffective": 4.02, "drug ineffective for unapproved indication": 35.53, "hereditary angioedema": 1165.07, "illness": 2.06, "infection": 2.28, "intentional product use issue": 84.31, "kidney infection": 14.4, "laryngeal oedema": 24.07, "maternal exposure during breast feeding": 10.08, "maternal exposure during pregnancy": 12.09, "nephrolithiasis": 9.01, "overdose": 2.87, "pharyngeal swelling": 136.57, "pneumonia": 3.04, "product dose omission issue": 5.93, "product use in unapproved indication": 13.94, "respiratory tract oedema": 256.68, "sepsis": 5.29, "sinusitis": 6.17, "therapeutic product effect incomplete": 20.71, "thrombosis": 5.03, "underdose": 20.5, "vascular access complication": 852.97, "vascular access site complication": 8572.17, "vascular device infection": 49.24}